Multicenter Evaluation of the BIOFIRE Blood Culture Identification 2 Panel for Detection of Bacteria, Yeasts, and Antimicrobial Resistance Genes in Positive Blood Culture Samples
Daniel D. Rhoads, Spyros Pournaras, Amy L. Leber, Joan-Miquel Balada-Llasat, Amanda Harrington, Vittorio Sambri, Rosemary C. She, Gregory J. Berry, Judy A. Daly, Caryn E. Good, Aikaterini Tarpatzi, Kathy Everhart, Tai Henry, Kathleen McKinley, Silvia Zannoli, Pil Pak, Fan Zhang, R.J. Barr, Kristen Holmberg, Bart Kensinger, Daisy Lu
Abstract
Diagnostic tools that can rapidly identify and characterize microbes growing in blood cultures are important components of clinical microbiology practice because they help to provide timely information that can be used to optimize patient management. This publication describes the bioMérieux BIOFIRE Blood Culture Identification 2 (BCID2) Panel clinical study that was submitted to the U.S.
Topics & Concepts
Blood cultureIdentification (biology)Clinical microbiologyAntimicrobialMicrobiologyBacteriaBiologyMedicineBiotechnologyAntibioticsGeneticsBotanyBacterial Identification and Susceptibility TestingDiphtheria, Corynebacterium, and TetanusStreptococcal Infections and Treatments